Boehringer Ingelheim Renews Global SRS License
News May 22, 2006
SRS has been in use at Boehringer Ingelheim for the past 5 years and is an integral part of its Bioinformatics platform.
As part of the renewal agreement BioWisdom SRS will be responsible for upgrading the Biberach (Germany) and Ridgefield (USA) sites to new versions of the software.
"Renewing customers is the best endorsement for the SRS product," said Gordon Smith Baxter, CEO of BioWisdom.
"Feedback from long term customers, such as Boehringer Ingelheim, is essential for the SRS team to continue to provide software with a strong value proposition and we are pleased to be working with them for another year."
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE